Women experience longer pain after injury due to biological differences in immune cells, a study finds.

Johnson & Johnson invests $1B in Pennsylvania to build a cell therapy plant, creating 4,500 jobs, part of a broader U.S. push for domestic advanced medicine manufacturing.

Cats and humans share key cancer genes, with study revealing similar tumor mutations and treatment responses, advancing precision medicine for both.

A new blood test may predict Alzheimer’s onset within 3–4 years, but isn’t yet reliable for healthy people.

FDA to shift from two to one clinical trial for most new drug approvals to accelerate access.

A Tetris-like game played after recalling trauma cuts flashbacks by 90%, offering a simple, scalable PTSD tool.

FDA approves new oral combo for untreated CLL, showing better outcomes than chemo.

India’s pharma exports hit $30.5B in 2024–25, with goals to reach $130B by 2030.

A small 2026 trial found DMT therapy rapidly reduced depression symptoms for up to six months in treatment-resistant adults.

Medtronic beat profit expectations in Q3 2026, driven by strong heart and diabetes device sales, and reaffirmed its 2026 earnings outlook.